$ 586 million
Completed
21/6/2016
Kurt Stumpo - Journalist - North America and the Caribbean
United States
Ireland
Israel
Public acquisition
M&A
Pharmaceuticals and life sciences
Party: Teva Pharmaceuticals (Seller)
Party: Impax Laboratories (Acquirer)